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Abstract 
Optical coherence tomography (OCT) is an imaging modality that enables assessment of tissue structural 
characteristics. Studies have indicated that OCT is a useful method to assess both blood vessel 
morphology and the response of a vessel to a deployed stent. We evaluated the ability of OCT to visualize 
the cellular lining of a tissue-engineered blood vessel mimic (BVM) and the response of this lining to a 
bare metal stent. We develop a side-firing endoscope that obtains intraluminal, longitudinal scans within 
the sterile bioreactor environment, enabling time-serial assessment. Seventeen BVMs are imaged with the 
endoscopic OCT system. The BVMs are then evaluated via fluorescence microscopy and/or standard 
histologic techniques. We determine that (1) the OCT endoscope can be repeatedly inserted without 
visible damage to the BVM cellular lining, (2) OCT provides a precise measure of cellular lining 
thickness with good correlation to measurements obtained from histological sections, and (3) OCT is 
capable of monitoring the accumulation of cellular material in response to a metallic stent. Our studies 
indicate that OCT is a useful technique for monitoring the BVM cellular lining, and that OCT may 
facilitate the use of BVMs for early stage device assessment.  
 
Keywords: optical coherence tomography; endoscope; tissue engineering; blood vessel mimic; stents. 
1 Introduction 
1.1 Optical Coherence Tomography in Vascular Imaging  
Optical coherence tomography (OCT) is a tissue-imaging modality that enables longitudinal and cross-
sectional assessment of tissue structure. OCT is analogous to ultrasound, except that near-IR light is used 
rather than sound, and signal is generated at index of refraction mismatches rather than acoustic index 
mismatches. With an axial resolution of approximately 10 µm, OCT provides an order of magnitude 
resolution improvement with a greater dynamic range as compared to commercially available 
intravascular ultrasound systems.1,2 The major trade-off accompanying these benefits is the smaller depth 
of penetration; OCT can image approximately 1 to 2 mm beneath the surface of typical tissues.  
Several studies have been performed evaluating OCT’s ability to assess blood vessel morphology and 
pathology. OCT has been used to evaluate the structural characteristics of the arterial wall, including 
thickness measurements of key arterial wall components such as the intimal and medial layers.3,4 The 
structural information provides a valuable tool in assessing different forms of atherosclerotic plaques, 
including the thin-cap fibroatheroma.1,5 Several researchers have used OCT to evaluate the deployment of 
coronary stents and the vascular response to these implants. OCT has been used to monitor stent 
deployment characteristics such as prolapse, 6–8 dissection,6,7 apposition,6,7 and recoil.9 Researchers have 
noted that OCT can be used to monitor the presence of a neointimal layer6,10–13 and thrombus14 in stented 
arteries. These studies demonstrate the utility of OCT for evaluating both native blood vessels and the 
tissue response to vascular interventions. 
 
1.2 OCT in Vascular Implant Development 
Although metal stents significantly reduce the occurrence of immediate vessel recoil following 
percutaneous transluminal coronary angioplasty, studies have shown that approximately 10 to 20% of 
patients require a secondary procedure due to restenosis.15–17 The rate of failure increases for high-risk 
populations such as diabetics.17,18 Advances are being made to reduce the incidence of in-stent restenosis, 
most notably drug- eluting stents.17 Additional research is being performed in the development and 
evaluation of bioresorbable stents.19–21  
To evaluate these new stent technologies, an assessment of the tissue response to the stent is required. The 
development of novel stent designs is prolonged by expensive and time- consuming animal and clinical 
trials. Moreover, the lack of an intravital, high-resolution imaging system to evaluate in-stent tissue 
responses results in limited temporal endpoints. Current technologies require sacrifice of the animal to 
retrieve the stent. Novel in vitro models are under development to provide rapid assessment of cellular 
responses to stents. As described by Cardinal et al., a blood vessel mimic (BVM) may serve as a system 
to model a human artery in vitro.22 Together with the minimally invasive, high-resolution visualization 
capabilities of OCT, the BVM has the potential to enable rapid and inexpensive evaluation of tissue 
response to various stent designs and drug coatings. 
A current problem associated with drug-eluting stents is the eventual development of a thrombus due to 
the presence of the nonendothelialized metallic stent. Although this in vitro system does not have the 
blood components necessary for a study of thrombogenesis, the BVM models the intimal response. 
Therefore, OCT can visualize the progression, (or lack thereof), of this antithrombogenic tissue lining. 
There has been limited previous research as to the utility of OCT for imaging tissue engineered 
constructs. Yang et al.23 imaged poly-l-lactic acid scaffolds sodded with MG63 bone cells. These 
constructs were removed from the culturing system, rinsed with saline, and then imaged with OCT. We 
have previously imaged a vascular construct consisting of smooth muscle cells sodded onto the luminal 
surface of a polyurethane scaffold. This construct was removed from its bioreactor and imaged while 
submerged in both saline and anticoagulated blood.24 Mason et al. visualized an artificial vessel 
constructed of human mesenchymal stem cell/alginate hydro- gel within a bioreactor, indicating that 
imaging grafts in a bioreactor is feasible. 25 However, none of these studies examined the utility of OCT 
for quantifying the development and response of a luminal cellular lining within the sterile envi-ronment 
of a bioreactor system. 
In this paper, we evaluate the use of OCT to visualize the cellular lining of a human BVM and the 
response of this lining following implantation of a stent. The aims of this study were to evaluate the 
feasibility of (1) introducing the OCT endoscope in a repeated, sterile fashion to obtain images without 
damaging the BVM; (2) obtaining accurate measurements of cellular lining thickness; and (3) visualizing 
the cellular lining response to bare metal stents.  
 
2 Materials and Methods 
2.1 OCT System 
Figure 1 presents a schematic of the OCT system. The source is a 1300-nm superluminescent diode 
(SLD) with a 100-nm bandwidth (SuperLum D1300-HP, Moscow, Russia), providing a measured axial 
resolution of 12 µm in air. The source was split into the sample and reference arms using a 50:50 fiber 
coupler. The power on the sample was measured to be 1.2 mW. The reference arm pathlength was 
modulated with the use of a rapid scanning optical delay line. 26 This setup was capable of producing a-
scan rates from 100 to 1000 a-scans/s, which were sufficient for imaging within these in vitro constructs. 
The interferometric signal was detected using a photodiode (Optiphase Model V500, Van Nuys, 
California) and demodulated using custom logarithmic amplifying circuitry. The signal was acquired and 
processed using custom C# software with a high-speed National Instruments data acquisition board (PCI-
6111, National Instruments, Austin, Texas). 
The sample arm of the interferometer was a miniature endoscope containing one OCT channel (single-
mode fiber) and three accessory channels (200-µm, multimode fibers). These accessory channels can be 
used for other imaging needs such as the insertion of an aiming beam or laser-induced fluorescence 
measurements. A similar endoscope design has been described previously.27 Light in the OCT channel 
was focused by a gradient-index (GRIN) lens, producing a lateral resolu-tion of 20 µm at a working 
distance of 400 µm outside the endoscopic window. A rod prism was used to direct the light out of the 
side of the endoscope window. Instead of using the standard 45-deg angle, the current rod prism was 
designed to have a 48-deg angle to reduce back-reflections from the glass endoscope window. The 
endoscopic optics such as the GRIN lens and rod prism were housed within a 2-mm-outer-diam, 40-mm-
long quartz optical window. Two stepper motors were used to rotate and translate the optics within the 
optical window, providing the means to image anywhere within the construct. The motion was transferred 
to the optics using an inner polyimide tubing, while the endoscopic window remained fixed in place by 
the outer sheath of the endoscope. 
An optional 20-cm-long quartz tube was used to provide a sterile cover for the endoscope. The 2.5-mm-
outer-diam, 2.2-mm-inner-diam windows InnovoQuartz were easily sterilized and were mechanically 
robust due to their small size.  A small amount of index-matching fluid was placed between the 
endoscope and the sterile window to reduce the reflections from the glass-air interfaces. Ethanol was 
typically used due to the low surface tension and slightly greater refractive index than water. 
 
2.2 Development and Imaging of the BVM 
The development of the BVM required three major components: a thin cellular lining, a scaffold 
supporting that lining, and a bioreactor system that provided nutrient rich media to the developing 
construct. 22 Many types of materials can be used as the synthetic scaffold including expanded 
polytetrafluoroethylene, Dacron®, polypropylene, and polyurethane.28 For these mimics, the tubular 
scaffold was made of the biocompatible, nondegradable expanded polytetrafluoroethylene (ePTFE). This 
common scaffold material is used clinically in large-diameter bypass grafts, and extensive research has 
been performed with ePTFE regarding modification techniques and endothelial cell growth and adhesion. 
Human microvessel endothelial cells were isolated from adipose tissue and pressure-sodded onto the 
luminal surface of the ePTFE. This procedure caused the formation of a thin, confluent cellular lining on 
the lumen of the scaffold. The construct was cultivated in the bioreactor for 14 to 21 days prior to 
imaging. 
All imaging occurred within the BVM chamber of the bioreactor system. Figure 2 shows schematics of 
the bioreactor and BVM chamber. The vertically-oriented BVM remained completely submerged in the 
bioreactor media. The endoscope was inserted into the plastic tubing of the bioreactor and fed into the 
BVM via a plastic barbed fitting. Once the endoscopic optics were adjacent to the distal connector, 
longitudinal scans were acquired by translating the optics in the proximal direction through the BVM. The 
OCT images were displayed such that the luminal surface, and thus the cellular lining, was located toward 
the top of the image. The length of each OCT image was 15 mm and the depth was 2 mm, assuming an 
average sample index of refraction of 1.33. Each image consisted of 3000 pixels in the longitudinal 
direction and 625 pixels in the depth direction and took approximately 15 s to acquire. 
 
2.3 Experiments 
Three sets of experiments with the BVMs were performed. The first experiment demonstrated the 
feasibility of imaging within a BVM without damage due to endoscopic insertion. Four BVMs were 
developed under identical protocols for 21 days. 22  Two BVMs were fixed immediately in Histo-choice, 
and two BVMs were imaged with the endoscopic OCT system prior to fixation. Longitudinal scans were 
obtained at four equally spaced angular positions within the mimic. Histological cross sections using 
standard paraffin embedding and hematoxylin and eosin (H&E) staining were prepared on all BVMs. 
The second experiment assessed the ability of OCT to characterize the BVM cellular lining within a 
bioreactor. To observe a variety of lining thicknesses, 12 BVMs were sodded with a range of initial 
cellular densities (2 X 105 to 8 X 105 cells/cm2). The vessels were allowed to develop in the bioreactor 
under flow for 14 days. 22 The BVMS were then imaged within the bioreactor using the endoscopic OCT 
system. Longitudinal scans were obtained at eight equally spaced angular positions. In addition to the 
equal angularly spaced images, an image was acquired over a longitudinal blue line painted onto the 
abluminal side of the vessel scaffold during manufacturing. After imaging, the BVMs were immediately 
fixed in Histochoice and histology was prepared as already describe, except that the sample was oriented 
longitudinally. The slice that passed through the centerline of the BVM and contained the longitudinal 
blue line was selected and compared to the OCT image taken at the angular position of the blue line. 
The thickness of the cellular lining was measured for all 12 vessels. A comparison was performed 
between OCT images and corresponding histological sections using statistical measures collected over the 
total length of the image. To facilitate these measurements, a MATLAB® (Mathworks, Version 7.0) 
program was developed that enabled the operator to specify two cubic spline curves identifying the 
luminal and abluminal surfaces of the cellular lining. The mean, median, and stan-dard deviation of the 
vertical separation of the curves were calculated. For thickness measurements in OCT, the index of 
refraction of the cellular lining was assumed to be 1.352, corresponding to a measurement of the intima, 
as reported by van der Meer et al.29  
The third experiment evaluated whether OCT could visualize the tissue response to a bare metal stent. 
One BVM was developed for 14 days. Before deployment of the stent, the BVM was imaged within the 
bioreactor to ensure a confluent lining of cells existed on the luminal surface of the ePTFE. A bare metal 
stent was then deployed in the BVM using a balloon catheter. The cellular response was imaged at 3, 7, 
and 14 days after stent deployment within the bioreactor using the same imaging protocol as the 
previously described experiment. 
 
3 Results and Discussion 
3.1 Robustness Study 
Two specific criteria were defined for a healthy, undisturbed cellular lining. These criteria were based on 
prior experience with BVM development and confirmed with the two BVMs that were immediately fixed 
without imaging. First, the histology of the BVM should show no bare areas, which would indicate that 
insertion or removal of the endoscope sheared off cells from the underlying ePTFE. On inspection of the 
cross- sectional histology of the two BVMs imaged with OCT, no suspected regions of cellular removal 
could be identified. The second criterion stated that the cellular lining should be firmly and continuously 
attached to the underlying ePTFE. A sepa-ration of the cells from the ePTFE could suggest that the 
endoscope had induced enough stress to weaken the interface between these two layers. Histology of the 
two BVMs imaged with the endoscope showed a cellular lining that was firmly attached to the underlying 
ePTFE. Overall, no anomalous features could be identified to indicate that imaging had damaged the 
cellular lining. These experiments suggest that with our imaging equipment and protocol, endoscopic 
imaging can be performed without visible damage or disruption to the cellular lining. 
 
3.2 Cellular Lining Measurement Study 
OCT images and histology slides were obtained from all 12 BVMs. Figure 3 shows an example OCT 
image/light micro-graph pair. The cellular lining is observed by OCT as a hy-pointense layer with an 
uneven luminal surface. The underlying scaffold is visualized as a hyperintense region. A distinct, smooth 
interface between the cellular lining and the scaffold can be seen in Fig. 3. The bioreactor media is 
transparent to the 1300-nm OCT light and thus is represented by the dark area above the cellular lining. 
The cellular lining morphology of the BVM can be modulated by adjusting developmental parameters 
such as the cellular sodding density. This provides opportunities to form unique, uneven cellular lining 
structures within the BVM. In Fig. 4 an OCT image and a light micrograph of the corresponding 
histological section are shown from a BVM that contained a cellular lining characterized by islands of 
cells congregating on the surface of the ePTFE. A high degree of correlation can be seen between these 
two types of images. 
The accurate visualization of this cellular lining reinforces the utility of OCT as a tool for on-going 
assessment. Currently, the BVMs are developed without directly monitoring the cellular lining. The 
endoscopic OCT system provides a minimally disruptive technique to observe the distribution and 
maturation of the cellular lining. 
The thickness of the cellular lining was measured from the OCT images. The minimum cellular lining 
thickness that could be detected by the OCT system was empirically found to be approximately 25 µm, 
more than two times larger than the axial resolution of the OCT light source. The ability of OCT to 
resolve the cellular lining was limited by the small difference in backscattered intensity between the 
cellular lining and scaffold. We also noted that islands of cells were easier to identify than a thin 
confluent cellular lining. 
A comparison between the average thickness measured with OCT and histology for each BVM can be 
seen in Fig. 5. The error bars are the standard deviation of the thickness measurements. Linear regression 
was performed on the data and a reasonable correlation was found with an R2 value of 0.71. While every 
attempt was made to register OCT and histological images using the blue line on the ePTFE as a fiducial, 
it is unlikely that the approximately 20-µm-thick OCT image and the 6-µm-thick histological section 
were exactly coaligned, which may be the major source of error. All measurement data would lie on a fit 
line with a slope of unity if histology exactly correlated to OCT. In this case, the slope was slightly 
greater than unity, indicating that OCT measured on average a 19% thicker layer than histology. This 
finding is consistent with the understanding that tissue preparation in the histological process causes 
shrinkage of the tissue. This difference of structural thickness measurements has been previously reported 
in OCT-histology comparisons of arterial wall components.4 
 
3.3 Response to a Metallic Stent 
Figure 6 displays a series of OCT images from the stented BVM. In this vessel, the prestent image in Fig. 
6(A) has a thin cellular lining on the luminal surface of the ePTFE. The cellular lining was thinner and 
more hyperintense than the 12 unstented BVMs. These differences are thought to be due to the lower 
sodding density and different flow conditions for this particular vessel. Based on previous experience 
with BVM development, lower sodding density, on average, results in a thinner cellular lining. The 
increased cellular density of this thinner lining could explain the more hyperintense presentation of the 
cellular lining in Fig. 6(A). 
After deployment, OCT visualized several features previously observed in studies of stented arteries. The 
stent struts were represented as bright horizontal lines with dark shadows underneath, consistent with 
previous studies involving stented human arteries.6–14 Occasional bright vertical streaks occurring near 
the struts are artifacts due to the strong reflection saturating the detection electronics. The typical strut 
width for the implanted stent was measured to be 80 µm wide with a bright-field microscope. However, 
the OCT imaging plane rarely intersects the stent struts perpendicularly, and may intersect the stent at a 
cross-member or strut branch point. Consequently, the reflections from the stent struts may be up to 750 
µm wide. Figure 6(B) shows a small amount of cellular material that was separated from the underlying 
ePTFE due to the deployment of the stent. While the BVM is obviously different in composition from 
atherosclerotic human arteries, other researchers have noted damage following stent deploy- ment such as 
intimal and medial vessel wall dissection. In this study, OCT also provided an accurate visualization of 
stent apposition to the BVM wall. Apposition characteristics of stented arteries have been observed using 
OCT by other researchers.6,7,13 
At 3 days postdeployment, OCT images showed the presence of additional material around the sides of 
the stent struts. The optical characteristics of this material were consistent with cellular lining. In the 
series of images acquired 3 days postdeployment, significant accumulation was visualized only along a 
few isolated stent struts, as shown in Fig. 6(C). At 7 days postdeployment, approximately half of the stent 
struts had associated areas of visible tissue formation. Accumulation near 2 of the 5 imaged stent struts 
can be seen in Fig. 6(D), where the most significant areas of development are indicated with white 
arrows. As seen in Fig. 6(E), at 14 days postdeployment the stent struts were uniformly covered by the 
cellular lining. The presence of cells in this tissue was later confirmed using a nuclear-specific fluorescent 
stain (bisbenzimide) and epifluorescence microscopic observation.22 This finding suggests that OCT 
imaging enables time-serial assessment of tissue response in association with stent struts. Although the 
cellular response of the stented BVM is not equivalent to stented human arteries, the two share a similar 
feature of the presence of cellular accumulation on the stent struts. 5,6,11–13 
 
The epifluorescence analysis with bis-benzimide-stained BVMs visualized a monolayer of cells on the 
stent struts at the 14-day time point. This monolayer was not detected in the corresponding OCT images. 
The thinness of the layer in this case precluded visualization, however, specular reflection from stent 
struts will diminish the ability to measure larger overlying cell linings. Frequently, stent struts reflected 
enough light to saturate the OCT system, as evidenced by vertical streaking [for example, in the enlarged 
portion of Fig. 6(B)]. Occasionally, saturation of the detection electronics occurred across the entire strut, 
increasing the full width half maximum of the axial point spread function from the surface of the strut on 
the order of 50 µm. This saturation may place a lower limit on the cell layer thickness that can be 
measured. To reduce the complications introduced by this saturation artifact, the endoscope was designed 
such that the light exited the endoscope slightly off angle (7.5 deg in water) to suppress the specular 
reflections from the stent struts as well as the endoscope window.  
 
4 Conclusions 
Our results suggest that OCT can be a valuable tool in (1) monitoring the development of the BVM 
cellular lining and (2) evaluating the cellular response to bare metal stents. Without contamination or 
physical disruption to the cellular lining, OCT provided thickness measurements that were consistent with 
those seen in corresponding histological sections, and visualized cellular accumulation near the struts of 
the metal stent. Future studies will assess the potential for using OCT to evaluate experimental stent 



































BVM response to bare metal stent: (A) a thin cellular lining was present before deployment; arrows 
delineate the thin hyperintense layer and (B) the postdeployment stent struts were visualized by a bright 
reflection followed by a dark vertical band.  Disruption of cellular lining was visualized (arrows in B). 
Areas of cellular accumulation on the stent struts were seen in the 3- and 7-day images (arrows in C and 
D). Extensive cellular accumulation was observed at day 14 (E). 
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